Two Sigma Securities’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,617
Closed -$25.4K 3429
2024
Q1
$25.4K Buy
+11,617
New +$36.8K ﹤0.01% 2652
2022
Q4
Sell
-10,160
Closed -$9K 3039
2022
Q3
$9K Buy
+10,160
New +$14.4K ﹤0.01% 2417

Other funds holding NEPH

Two Sigma Securities's NEPH Position: Q2 2024 in Review

Two Sigma Securities sold out of Nephros (NEPH) in Q2 2024, closing a stake of 11,617 shares — an estimated $25.4K sold.

Two Sigma Securities first reported a position in NEPH in Q3 2022 and held it in 2 quarters. The position peaked at $25.4K in Q1 2024. 19 funds tracked by Wall St. Rank hold NEPH as of Q2 2024.

  • Two Sigma Securities reported no remaining Nephros position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 11,617 Nephros shares in Q2 2024, an estimated $25.4K.
  • Two Sigma Securities first reported a position in Nephros in Q3 2022 and held it in 2 quarters.
  • Two Sigma Securities's Nephros position peaked at $25.4K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Nephros as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.